SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-062004
Filing Date
2019-11-12
Accepted
2019-11-12 07:00:40
Documents
16
Period of Report
2019-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1922462-1_8k.htm   iXBRL 8-K 26558
2 EXHIBIT 99.1 tm1922462d1_99-1.htm EX-99.1 187579
3 EXHIBIT 99.2 tm1922462d1_99-2.htm EX-99.2 14933
7 GRAPHIC tm1922462d1_99-2img01.jpg GRAPHIC 10686
8 GRAPHIC tm1922462d1_99-1img01.jpg GRAPHIC 11300
  Complete submission text file 0001104659-19-062004.txt   459384

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA egrx-20191112.xsd EX-101.SCH 3183
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE egrx-20191112_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE egrx-20191112_pre.xml EX-101.PRE 22708
10 EXTRACTED XBRL INSTANCE DOCUMENT tm1922462-1_8k_htm.xml XML 3619
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 191205986
SIC: 2834 Pharmaceutical Preparations